584 related articles for article (PubMed ID: 25498217)
21. The DNA methylome of glioblastoma multiforme.
Martinez R; Esteller M
Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells.
Waha A; Felsberg J; Hartmann W; von dem Knesebeck A; Mikeska T; Joos S; Wolter M; Koch A; Yan PS; Endl E; Wiestler OD; Reifenberger G; Pietsch T; Waha A
Cancer Res; 2010 Feb; 70(4):1689-99. PubMed ID: 20124482
[TBL] [Abstract][Full Text] [Related]
23. DNA methyltransferase-mediated transcriptional silencing in malignant glioma: a combined whole-genome microarray and promoter array analysis.
Foltz G; Yoon JG; Lee H; Ryken TC; Sibenaller Z; Ehrich M; Hood L; Madan A
Oncogene; 2009 Jul; 28(29):2667-77. PubMed ID: 19465937
[TBL] [Abstract][Full Text] [Related]
24. Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.
Castelo-Branco P; Choufani S; Mack S; Gallagher D; Zhang C; Lipman T; Zhukova N; Walker EJ; Martin D; Merino D; Wasserman JD; Elizabeth C; Alon N; Zhang L; Hovestadt V; Kool M; Jones DT; Zadeh G; Croul S; Hawkins C; Hitzler J; Wang JC; Baruchel S; Dirks PB; Malkin D; Pfister S; Taylor MD; Weksberg R; Tabori U
Lancet Oncol; 2013 May; 14(6):534-42. PubMed ID: 23598174
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway.
Yin H; Deng Z; Li X; Li Y; Yin W; Zhao G; Jiang D; Sun C; Zhou Y
Cancer Genet; 2019 Sep; 237():1-9. PubMed ID: 31447061
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma.
Lambertz N; El Hindy N; Kreitschmann-Andermahr I; Stein KP; Dammann P; Oezkan N; Mueller O; Sure U; Zhu Y
BMC Cancer; 2015 Oct; 15():759. PubMed ID: 26490252
[TBL] [Abstract][Full Text] [Related]
27. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
[TBL] [Abstract][Full Text] [Related]
28. Post-transcriptional regulation of O(6)-methylguanine-DNA methyltransferase MGMT in glioblastomas.
Ramakrishnan V; Kushwaha D; Koay DC; Reddy H; Mao Y; Zhou L; Ng K; Zinn P; Carter B; Chen CC
Cancer Biomark; 2011-2012; 10(3-4):185-93. PubMed ID: 22674304
[TBL] [Abstract][Full Text] [Related]
29. Elevated expression of Notch-1 and EGFR induced apoptosis in glioblastoma multiforme patients.
Xing ZY; Sun LG; Guo WJ
Clin Neurol Neurosurg; 2015 Apr; 131():54-8. PubMed ID: 25704190
[TBL] [Abstract][Full Text] [Related]
30. Effect of 5-Aza-2'-deoxycytidine on SLC22A18 in glioma U251 cells.
Chu SH; Ma YB; Feng DF; Zhang H; Qiu JH; Zhu ZA
Mol Med Rep; 2012 Jan; 5(1):138-41. PubMed ID: 21993522
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential serum biomarkers of glioblastoma: serum osteopontin levels correlate with poor prognosis.
Sreekanthreddy P; Srinivasan H; Kumar DM; Nijaguna MB; Sridevi S; Vrinda M; Arivazhagan A; Balasubramaniam A; Hegde AS; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1409-22. PubMed ID: 20530493
[TBL] [Abstract][Full Text] [Related]
33. Integrated analysis using methylation and gene expression microarrays reveals PDE4C as a prognostic biomarker in human glioma.
Bao Z; Feng Y; Wang H; Zhang C; Sun L; Yan Z; Liu Q; Guo T; Li M; Yang X; Jiang C; Zhang Q; Jiang T
Oncol Rep; 2014 Jul; 32(1):250-60. PubMed ID: 24842301
[TBL] [Abstract][Full Text] [Related]
34. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth.
Bui TT; Nitta RT; Kahn SA; Razavi SM; Agarwal M; Aujla P; Gholamin S; Recht L; Li G
BMC Cancer; 2015 Apr; 15():225. PubMed ID: 25884624
[TBL] [Abstract][Full Text] [Related]
35. Role of Wnt5a in the proliferation of human glioblastoma cells.
Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS
Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
[TBL] [Abstract][Full Text] [Related]
37. The miR-92b functions as a potential oncogene by targeting on Smad3 in glioblastomas.
Wu ZB; Cai L; Lin SJ; Lu JL; Yao Y; Zhou LF
Brain Res; 2013 Sep; 1529():16-25. PubMed ID: 23892108
[TBL] [Abstract][Full Text] [Related]
38. Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.
Amoureux MC; Coulibaly B; Chinot O; Loundou A; Metellus P; Rougon G; Figarella-Branger D
BMC Cancer; 2010 Mar; 10():91. PubMed ID: 20219118
[TBL] [Abstract][Full Text] [Related]
39. NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.
Guo Q; Han N; Shi L; Yang L; Zhang X; Zhou Y; Yu S; Zhang M
Oncol Rep; 2019 Sep; 42(3):963-972. PubMed ID: 31322259
[TBL] [Abstract][Full Text] [Related]
40. Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma.
Chu SH; Feng DF; Ma YB; Zhang H; Zhu ZA; Li ZQ; Jiang PC
J Transl Med; 2011 Sep; 9():156. PubMed ID: 21936894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]